214 related articles for article (PubMed ID: 14652304)
1. Case-control study of bladder cancer and drinking water arsenic in the western United States.
Steinmaus C; Yuan Y; Bates MN; Smith AH
Am J Epidemiol; 2003 Dec; 158(12):1193-201. PubMed ID: 14652304
[TBL] [Abstract][Full Text] [Related]
2. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.
Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO
Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of bladder cancer and arsenic in drinking water.
Bates MN; Smith AH; Cantor KP
Am J Epidemiol; 1995 Mar; 141(6):523-30. PubMed ID: 7900719
[TBL] [Abstract][Full Text] [Related]
4. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.
Smith AH; Goycolea M; Haque R; Biggs ML
Am J Epidemiol; 1998 Apr; 147(7):660-9. PubMed ID: 9554605
[TBL] [Abstract][Full Text] [Related]
5. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
Chiou HY; Chiou ST; Hsu YH; Chou YL; Tseng CH; Wei ML; Chen CJ
Am J Epidemiol; 2001 Mar; 153(5):411-8. PubMed ID: 11226969
[TBL] [Abstract][Full Text] [Related]
6. Case-control study of bladder cancer and exposure to arsenic in Argentina.
Bates MN; Rey OA; Biggs ML; Hopenhayn C; Moore LE; Kalman D; Steinmaus C; Smith AH
Am J Epidemiol; 2004 Feb; 159(4):381-9. PubMed ID: 14769642
[TBL] [Abstract][Full Text] [Related]
7. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
Tsuji JS; Alexander DD; Perez V; Mink PJ
Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
[TBL] [Abstract][Full Text] [Related]
8. Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation.
Steinmaus CM; Ferreccio C; Romo JA; Yuan Y; Cortes S; Marshall G; Moore LE; Balmes JR; Liaw J; Golden T; Smith AH
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):623-30. PubMed ID: 23355602
[TBL] [Abstract][Full Text] [Related]
9. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
[TBL] [Abstract][Full Text] [Related]
10. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada.
Warner ML; Moore LE; Smith MT; Kalman DA; Fanning E; Smith AH
Cancer Epidemiol Biomarkers Prev; 1994; 3(7):583-90. PubMed ID: 7827589
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
Karagas MR; Stukel TA; Tosteson TD
Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of arsenic in drinking water and lung cancer in California and Nevada.
Dauphiné DC; Smith AH; Yuan Y; Balmes JR; Bates MN; Steinmaus C
Int J Environ Res Public Health; 2013 Aug; 10(8):3310-24. PubMed ID: 23917816
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer and arsenic concentrations in drinking water in Chile.
Ferreccio C; González C; Milosavjlevic V; Marshall G; Sancha AM; Smith AH
Epidemiology; 2000 Nov; 11(6):673-9. PubMed ID: 11055628
[TBL] [Abstract][Full Text] [Related]
14. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
[TBL] [Abstract][Full Text] [Related]
15. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.
Karagas MR; Tosteson TD; Blum J; Morris JS; Baron JA; Klaue B
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1047-50. PubMed ID: 9703491
[TBL] [Abstract][Full Text] [Related]
16. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A
Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466
[TBL] [Abstract][Full Text] [Related]
17. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
18. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
[TBL] [Abstract][Full Text] [Related]
19. Elevated lung cancer in younger adults and low concentrations of arsenic in water.
Steinmaus C; Ferreccio C; Yuan Y; Acevedo J; González F; Perez L; Cortés S; Balmes JR; Liaw J; Smith AH
Am J Epidemiol; 2014 Dec; 180(11):1082-7. PubMed ID: 25371173
[TBL] [Abstract][Full Text] [Related]
20. Potential effect modifiers of the arsenic-bladder cancer risk relationship.
Koutros S; Baris D; Waddell R; Beane Freeman LE; Colt JS; Schwenn M; Johnson A; Ward MH; Hosain GM; Moore LE; Stolzenberg-Solomon R; Rothman N; Karagas MR; Silverman DT
Int J Cancer; 2018 Dec; 143(11):2640-2646. PubMed ID: 29981168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
